IP Library Granted Patent US 7,645,783
Granted Patent B2
US 7,645,783 · App. 11/865,532 · Granted Jan 12, 2010

Halogenated benzamide derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,645,783
App. No.
11/865,532
Granted
Jan 12, 2010
Kind
B2
Abstract

A method of treating viral infections by the administration of a halogenated benzamide derivative according to formula (III): in which R 1 is a halogen atom, and R 2 -R 6 are independently hydrogen, hydroxyl, C 1 -C 4 alkyl, —C 1 -C 4 alkoxy, acyloxy, nitro, halogen, —C(O)R 7 where R 7 is —C 1 -C 4 alkyl, or, aromatic including salts and hydrates of these compounds.

Claims (6)

1. A method for treating viral infections, comprising administering to a subject in need of treatment an effective amount of a pharmaceutical composition comprising as active agent a compound according to formula (III):

in which R 1 is a halogen atom, and R 2 -R 6 are independently hydrogen, hydroxyl, C 1 -C 4 alkyl, —C 1 -C 4 alkoxy, acyloxy, nitro, halogen, —C(O)R 7 where R 7 is —C 1 -C 4 alkyl, or, aromatic including salts and hydrates of these compounds, wherein at least one of R 2 -R 6 is other than hydrogen.

2. A method for treating viral infections, comprising administering to a subject in need of treatment an effective amount of a pharmaceutical composition comprising as active agent a compound according to formula (III):

wherein R 1 is a halogen atom, and R 2 -R 6 are independently hydrogen, hydroxyl, C 1 -C 4 alkyl, —C 1 -C 4 alkoxy, acyloxy, —C(O)R 7 where R 7 is —C 1 -C 4 alkyl, or, aromatic including salts and hydrates of these compounds, wherein at least one of R 2 -R 6 is other than hydrogen.

3. A method for treating viral infections, comprising administering to a subject in need of treatment an effective amount of a pharmaceutical composition comprising as active agent a compound according to formula (III):

wherein is a halogen atom, R 2 -R 6 are independently hydrogen, halogen, nitro, hydroxyl, C 1 -C 4 alkyl, —C 1 -C 4 alkoxy, acyloxy, —C(O)R 7 where R 7 is —C 1 -C 4 alkyl, or, aromatic including salts and hydrates of these compounds, wherein at least two of R 2 -R 6 is other than hydrogen and at least one of R 2 -R 6 is hydroxyl or acyloxy.

Assignments (11)
SECURITY INTEREST Recorded Nov 16, 2019
From: ROMARK BIOSCIENCES S.À R.L. LLC; ROMARK LABORATORIES, L.C.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051030/0613 →
SECURITY INTEREST Recorded Jul 2, 2018
From: ROMARK BIOSCIENCES S.À R.L. LLC; ROMARK LABORATORIES, L.C.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 046254/0524 →
SECURITY INTEREST Recorded Dec 22, 2017
From: ROMARK BIOSCIENCES S.À R.L. LLC; ROMARK LABORATORIES, L.C.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 044472/0001 →
RELEASE OF SECURITY INTEREST Recorded Mar 6, 2015
From: U.S. BANK NATIONAL ASSOCIATION
To: ROMARK LABORATORIES, L.C.; ROMARK MANUFACTURING, LLC; LAPICOR, N.V.
Reel/Frame 035108/0474 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: ROMARK LABORATORIES, L.C.; ROMARK MANUFACTURING, LLC; LAPICOR, N.V.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 031156/0923 →
RELEASE OF SECURITY INTEREST Recorded Sep 3, 2013
From: PAUL CAPITAL FUND MANAGEMENT, L.L.C.
To: ROMARK LABORATORIES, L.C.
Reel/Frame 031159/0636 →
CHANGE OF NAME Recorded Jul 29, 2011
From: LAMINAR DIRECT CAPITAL L.P.
To: LAMINAR DIRECT CAPITAL, L.L.C. (FORMERLY KNOWN AS LAMINAR DIRECT CAPITAL L.P.)
Reel/Frame 026676/0386 →
RELEASE OF SECURITY INTEREST Recorded Jul 29, 2011
From: LAMINAR DIRECT CAPITAL, L.L.C. (FORMERLY KNOWN AS LAMINAR DIRECT CAPITAL L.P.)
To: ROMARK LABORATORIES, L.C.
Reel/Frame 026676/0576 →
SECURITY AGREEMENT Recorded Jul 29, 2011
From: ROMARK LABORATORIES, L.C.
To: PAUL CAPITAL FUND MANAGEMENT, L.L.C.
Reel/Frame 026676/0635 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 28, 2009
From: ROMARK LABORATORIES, L.C.
To: LAMINAR DIRECT CAPITAL, L.L.C., AS COLLATERAL AGENT
Reel/Frame 023282/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2008
From: ROSSIGNOL, JEAN FRANCOIS
To: ROMARK LABORATORIES L.C.
Reel/Frame 020358/0660 →